1. Home
  2. NSPR vs TSE Comparison

NSPR vs TSE Comparison

Compare NSPR & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • TSE
  • Stock Information
  • Founded
  • NSPR 2005
  • TSE 2010
  • Country
  • NSPR United States
  • TSE United States
  • Employees
  • NSPR N/A
  • TSE N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • TSE Major Chemicals
  • Sector
  • NSPR Health Care
  • TSE Industrials
  • Exchange
  • NSPR Nasdaq
  • TSE Nasdaq
  • Market Cap
  • NSPR 74.8M
  • TSE 84.1M
  • IPO Year
  • NSPR N/A
  • TSE 2014
  • Fundamental
  • Price
  • NSPR $2.38
  • TSE $2.61
  • Analyst Decision
  • NSPR Strong Buy
  • TSE
  • Analyst Count
  • NSPR 2
  • TSE 0
  • Target Price
  • NSPR $4.50
  • TSE N/A
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • TSE 384.4K
  • Earning Date
  • NSPR 08-05-2025
  • TSE 08-06-2025
  • Dividend Yield
  • NSPR N/A
  • TSE 1.81%
  • EPS Growth
  • NSPR N/A
  • TSE N/A
  • EPS
  • NSPR N/A
  • TSE N/A
  • Revenue
  • NSPR $7,066,000.00
  • TSE $3,258,300,000.00
  • Revenue This Year
  • NSPR $4.85
  • TSE N/A
  • Revenue Next Year
  • NSPR $113.47
  • TSE $4.39
  • P/E Ratio
  • NSPR N/A
  • TSE N/A
  • Revenue Growth
  • NSPR 7.60
  • TSE N/A
  • 52 Week Low
  • NSPR $1.99
  • TSE $1.90
  • 52 Week High
  • NSPR $3.80
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • TSE 51.19
  • Support Level
  • NSPR $2.35
  • TSE $2.17
  • Resistance Level
  • NSPR $2.52
  • TSE $2.60
  • Average True Range (ATR)
  • NSPR 0.14
  • TSE 0.19
  • MACD
  • NSPR -0.02
  • TSE 0.03
  • Stochastic Oscillator
  • NSPR 7.50
  • TSE 80.57

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: